Qinlock 50 mg, Tabletten
7680681990024
CH-68199
Tabletten
Associated product:
QINLOCK cpr 50 mg fl 90 pce
1 / 3
google
Article details
- Package size
- 90
- Selling units
- 90
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ripretinibum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
179.0 MG | Substance | HBESI |
|
crospovidonum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 18514.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
Deciphera Pharmaceuticals
6300 Zug
Authorization information
- Swissmedic authorization number
- 68199
- Drug name
- Qinlock, Tabletten
- Galenic form
- TAB
- ATC Code
- L01EX19
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 07/10/2021
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- QINLOCK cpr 50 mg fl 90 pce
- Description (DE)
- QINLOCK Tabl 50 mg Fl 90 Stk
- Market launch
- 07/10/2021
- Narcotic (BTM)
- No